Individual prediction of heart failure among childhood cancer survivors.
about
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclinesEquivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for TreatmentLate Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.Involved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adultsLate Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.Intimacy, Substance Use, and Communication Needs During Cancer Therapy: A Report From the "Resilience in Adolescents and Young Adults" Study.Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study.Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.Cardiomyopathy in Childhood Cancer Survivors: Lessons from the Past and Challenges for the Future.Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors.Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines.The Positive Effects of Exercise in Chemotherapy-Related Cardiomyopathy.Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer.Yield of screening echocardiograms during pediatric follow-up in survivors treated with anthracyclines and cardiotoxic radiation.State of the art review: Chemotherapy-induced cardiotoxicity in children.Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies.A threshold-free summary index of prediction accuracy for censored time to event data.Development and Validation of a Clinical Score for Cardiovascular Risk Stratification of Long-Term Childhood Cancer Survivors.Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.Cardio-Oncology - A new subspecialty with collaboration at its heart.Pregnancy and Cardiomyopathy After Anthracyclines in Childhood.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
P2860
Q33640172-746D1132-CA30-4704-B33D-65DC2ACC2262Q35754395-EA9166D7-69A4-4CC6-B844-B7031D831347Q35833419-BD8FB4D2-BCB4-4BBE-8C74-DA3CE9837122Q35947024-45839676-A4B4-47A2-8939-16F096E54297Q36450854-3515D82C-7B9B-44AA-8D5B-7B5B327DE2A7Q36783762-9D4A46FD-92B3-4C22-8B3D-3DBBA0A359E5Q37582448-414311B8-EB9B-460C-B559-05FC1C8B3D2CQ37598919-0769A674-58F2-4C3C-A029-FA1B21CE6D9DQ37613120-CAB8EB9F-04AE-4321-A93E-81BFB83D3D1CQ38545052-FBE75087-C76C-42CA-A78E-54B176C6FD87Q38753035-E0480623-C4C7-4172-9ABF-70E8792B74A2Q38836695-2407E706-9C41-4755-9149-60460A926B96Q39078275-11E78C47-F467-42C6-8D6F-A5E4FD020B9FQ40065987-853EDF9F-E931-42FD-8816-37AFFDE1B84BQ41430035-3F891ADA-872E-4E64-BE74-43CA40FCCC3AQ46269647-D9EA382D-2E13-43ED-8DD3-98F8B4206019Q47863728-57B7B9F7-AEAE-4907-A90B-8A0B3407140AQ47918169-65619D8D-8944-4A49-A88F-A8DFA5E4F03BQ48143732-E7DBE8D1-1E0D-4902-9E2E-C28DF765A652Q48222615-E5F56AE6-D7E4-4803-BEEB-60D61E5E6775Q50052080-FBC1AB1D-54F6-4B04-BE1A-F6246D84A933Q51733243-00A7DB58-EDAA-441F-A60F-942E176207B2Q53075042-2AA548DC-0355-4F65-886D-7B8AA8464187Q53104651-A4552DE2-5C94-4DDE-86CA-DFEC5126C529Q55118422-2292F665-66F4-4257-832F-D44529270B00Q57057499-CF403C0D-2AA1-410B-BE17-996019E2953C
P2860
Individual prediction of heart failure among childhood cancer survivors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Individual prediction of heart failure among childhood cancer survivors.
@ast
Individual prediction of heart failure among childhood cancer survivors.
@en
type
label
Individual prediction of heart failure among childhood cancer survivors.
@ast
Individual prediction of heart failure among childhood cancer survivors.
@en
prefLabel
Individual prediction of heart failure among childhood cancer survivors.
@ast
Individual prediction of heart failure among childhood cancer survivors.
@en
P2093
P2860
P356
P1476
Individual prediction of heart failure among childhood cancer survivors
@en
P2093
Charles A Sklar
Daniel A Mulrooney
Daniel M Green
Elizabeth A M Feijen
Gregory T Armstrong
Helena J van der Pal
Kathleen A Meeske
Kevin C Oeffinger
Kirsten K Ness
Leontien C Kremer
P2860
P304
P356
10.1200/JCO.2014.56.1373
P407
P50
P577
2014-10-06T00:00:00Z